Tuberculous meningitis in HIV-infected individuals.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 3131531)

Published in Curr HIV/AIDS Rep on August 01, 2009

Authors

Christopher Vinnard1, Rob Roy Macgregor

Author Affiliations

1: Division of Infectious Disease, Hospital of the University of Pennsylvania, 3400 Spruce Street, 3 Silverstein, Suite E, Philadelphia, PA 19104, USA. christopher.vinnard@uphs.upenn.edu

Articles citing this

HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev (2011) 3.28

Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med (2013) 1.66

Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration. J Infect Dis (2011) 1.31

Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med (2010) 1.08

Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology (2012) 0.91

Tuberculous meningitis in patients infected with human immunodeficiency virus. J Neurol (2010) 0.86

Clinical Profile of Neurological Manifestation in Human Immunodeficiency Virus-positive Patients. N Am J Med Sci (2012) 0.81

TNF-dependent regulation and activation of innate immune cells are essential for host protection against cerebral tuberculosis. J Neuroinflammation (2015) 0.80

Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study. AIDS Res Ther (2013) 0.80

TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortality. Biomed Res Int (2013) 0.79

MRI findings in children with tuberculous meningitis: a comparison of HIV-infected and non-infected patients. Childs Nerv Syst (2011) 0.77

Comparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis. J Clin Microbiol (2014) 0.75

Chromosomal rearrangements and protein globularity changes in Mycobacterium tuberculosis isolates from cerebrospinal fluid. PeerJ (2016) 0.75

Clinical Presentation, Aetiology, and Outcomes of Meningitis in a Setting of High HIV and TB Prevalence. J Trop Med (2015) 0.75

A Patient Presenting with Tuberculous Encephalopathy and Human Immunodeficiency Virus Infection. Am J Case Rep (2016) 0.75

Stroke in a Patient with Tuberculous Meningitis and HIV Infection. Mediterr J Hematol Infect Dis (2013) 0.75

Articles cited by this

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med (2004) 10.14

Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med (1992) 8.15

Treatment of tuberculosis. MMWR Recomm Rep (2003) 5.41

Tuberculosis of the central nervous system. Postgrad Med J (1999) 3.63

Tuberculosis and HIV infection in sub-Saharan Africa. JAMA (1992) 3.51

Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol (2002) 3.02

Tuberculous meningitis: many questions, too few answers. Lancet Neurol (2005) 2.90

Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev (2008) 2.88

Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr (2000) 2.86

Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet (2001) 2.72

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Lancet (1999) 2.62

Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol (2004) 2.60

Tuberculous meningitis: a 30-year review. Clin Infect Dis (1993) 2.48

The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis (2005) 2.38

Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis (2005) 2.29

Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis (1994) 2.19

Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis (1996) 2.14

Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol (2004) 1.64

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000. Clin Infect Dis (2005) 1.63

Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis. Clin Infect Dis (2003) 1.63

Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg (1998) 1.52

Tuberculous meningitis in South African urban adults. QJM (1998) 1.48

Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. Antimicrob Agents Chemother (2004) 1.44

The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci (2000) 1.41

HIV-associated tuberculosis: diagnostic and treatment challenges. Semin Respir Crit Care Med (2008) 1.26

Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med (1992) 1.21

The spectrum of meningitis in a population with high prevalence of HIV disease. QJM (1996) 1.19

Tuberculous meningitis. Infect Dis Clin North Am (1990) 1.14

Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis (1993) 1.14

Tuberculous meningitis--clinical and laboratory review of 100 patients. J Hyg (Lond) (1986) 1.05

Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J (2006) 1.03

Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital. Arch Intern Med (1996) 1.01

Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J Infect (2005) 0.99

Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis. Infection (2001) 0.97

The prognostic factors of adult tuberculous meningitis. Infection (2001) 0.97

Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Int J Tuberc Lung Dis (2002) 0.95

Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome. AIDS (2007) 0.92

Mortality associated with central nervous system tuberculosis. J Infect (2007) 0.90

Tuberculous meningitis and HIV. Indian J Pediatr (2005) 0.88

Tuberculous meningitis in children: a retrospective study of 79 patients, with an analysis of prognostic factors. Can Med Assoc J (1979) 0.85

Magnetic resonance imaging in diagnosis of childhood central nervous system tuberculosis. Infection (2001) 0.84

Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis (2003) 0.84

Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection. Arch Neurol (1996) 0.83

Factors associated to the positive cerebrospinal fluid culture in the tuberculous meningitis. Arq Neuropsiquiatr (2007) 0.83

Tuberculous meningitis: is a 6-month treatment regimen sufficient? Int J Tuberc Lung Dis (2001) 0.79

[Tuberculous meningitis: clinical, biological and x-ray computed tomographic comparison between patients with or without HIV infection]. Presse Med (1997) 0.77